Remove Kidney Disease Remove Obesity Remove Patient Care
article thumbnail

Cardiometabolic Health Congress (CMHC) will present the results of a webcast series designed to help practitioners improve patient care

Cardiometabolic Health Congress

The session will detail the results of a webcast series on better managing obesity in patients with type 2 diabetes, significantly improving their knowledge and treatment practices. The program led to increases in knowledge and competence regarding new weight management therapies and effective long-term obesity treatment.

article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The future of care demands a holistic approach.

Education 100
article thumbnail

Cardiometabolic Health Congress Becomes First Organization to Offer Certification in Cardiometabolic Health

Cardiometabolic Health Congress

2023, the American Heart Association (AHA) issued a presidential advisory on the urgency of this systemic disorder involving heart disease, kidney disease, diabetes and obesity. The virtual, self-paced Foundations of Cardiometabolic Health Certificate Course is the first step to attaining the CCHP credential.

article thumbnail

19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. George L. Bakris

Cardiometabolic Health Congress

Themed “Decoding the Constellation of Cardiometabolic Health and Risk Factors,” this year’s congress will tackle the growing health threat posed by cardiometabolic diseases, affecting 47 million people in the US. Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J. Contact Data Megan Magana, Sr.

CME 72
article thumbnail

Top 10 Cardiac Diagnosis Trends in 2024

GEMMS

These advancements, alongside software enhancements, enable early detection of cardiac diseases, empowering healthcare providers to make evidence-based decisions and tailor appropriate patient care plans. Genetic testing and DNA sequencing improve the accuracy of predicting heart disease risk.